DGS Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $302K | Sell |
3,272
-302
| -8% | -$27.9K | 0.08% | 218 |
|
|
2024
Q3 | $300K | Sell |
3,574
-1,492
| -29% | -$125K | 0.08% | 217 |
|
|
2024
Q2 | $348K | Sell |
5,066
-3,743
| -42% | -$257K | 0.1% | 189 |
|
|
2024
Q1 | $645K | Buy |
8,809
+1,021
| +13% | +$74.8K | 0.18% | 108 |
|
|
2023
Q4 | $631K | Buy |
7,788
+122
| +2% | +$9.88K | 0.24% | 82 |
|
|
2023
Q3 | $574K | Buy |
7,666
+934
| +14% | +$70K | 0.28% | 80 |
|
|
2023
Q2 | $519K | Buy |
6,732
+162
| +2% | +$12.5K | 0.26% | 85 |
|
|
2023
Q1 | $545K | Buy |
6,570
+131
| +2% | +$10.9K | 0.3% | 74 |
|
|
2022
Q4 | $553K | Sell |
6,439
-144
| -2% | -$12.4K | 0.36% | 60 |
|
|
2022
Q3 | $406K | Buy |
6,583
+1,619
| +33% | +$99.9K | 0.27% | 75 |
|
|
2022
Q2 | $307K | Buy |
+4,964
| New | +$307K | 0.25% | 102 |
|